In June 2020, the new “Regulations on the Supervision and Administration of Cosmetics” (CSAR) was finally issued and published in China. This is the first revision of the “Regulations on Hygiene Supervision of Cosmetics” (CHSR) since its publication in 1989. As the basic and fundamental legislation for cosmetics, CSAR has a far-reaching impact on the whole industry and also reveals new trends in scientific research work. To provide an interpretation of this regulation and help enterprises and researchers better understand the new policies, in this study, the main contents of CSAR and its regulatory system were introduced, and the major changes and background considerations were summarized, especially in the definition and scope of cosmetics, classification and categorization, ingredient management, safety evaluation, efficacy substantiation and technical evaluation work. A brief review of technical progress worldwide and a comparison of regulatory requirements were provided where necessary. Finally, new prospects of cosmetic science in China were discussed. In conclusion, CSAR will initiate a renewed and integrated regulatory system for cosmetics. Advanced concepts of supervision, encouragement of innovation, utilization of technical approaches and emphasis on scientific investigations are reflected in the regulations, which will deeply influence the development of both cosmetic products and new ingredients. With all these new challenges and opportunities, everyone involved should get prepared.
Assessing cosmetic quality, safety, and effectiveness demands advanced in situ, real-time, and multi-dimensional analytical technologies, while conventional methods suffer from complex sample preparation and incomplete analysis. Raman spectroscopy, with its non-invasiveness, specific molecular fingerprint, and micron-level spatial resolution, has become a key tool for cosmetic analysis. Based on a comprehensive review of the literature from 2000 to 2025, this article systematically examined the application of Raman spectroscopy in cosmetic analysis. The systematic search and screening process ensured the comprehensiveness and rigor of the review’s research foundation, as the 69 high-quality studies covered all core application areas of Raman spectroscopy in cosmetic analysis, providing solid literature support for subsequent technical summaries and trend analysis. This article systematically reviews the application of Raman spectroscopy in the cosmetic industry for ingredient detection (approved ingredients and hazardous substances), quality control (authenticity verification and production traceability), transdermal mechanism analysis (penetration pathways and interaction with skin barriers), and efficacy assessment. Combined with typical research cases, this study examined the technical principles and practical value, as well as the limitations and shortcomings of Raman technology applications. It ultimately provides suggestions for future developments in terms of portability, intelligence, and standardization, offering references for researchers to enable technological innovation and regulatory improvements in the cosmetics industry.
1 January 2012 in Chinese Journal of Analytical Chemistry
In this study, the oral bioavailability of Pb, Cd, and As in three types of traditional Chinese medicines (TCMs) and TCM decoctions were investigated through in vitro PBET digestion/MDKC cell model. Furthermore, a novel cumulative risk assessment model associated with co-exposure of heavy metal(loid)s in TCM and TCM decoction based on bioavailability was developed using hazard index (HI) for rapid screening and target organ toxicity dose modification of the HI (TTD) method for precise assessment. The results revealed that the bioavailability of Pb, Cd, and As in three types of TCM and TCM decoction was 5.32–72.49% and 4.98–51.97%, respectively. After rapid screening of the co-exposure health risks of heavy metal(loid)s by the HI method, cumulative risk assessment results acquired by TTD method based on total metal contents in TCMs indicated that potential health risks associated with the co-exposure of Pb, Cd, and As in Pheretima aspergillum (E. Perrier) and Oldenlandia diffusa (Willd.) Roxb were of concern. However, considering both the factors of decoction and bioavailability, TTD-adjusted HI outcomes for TCMs in this study were <1, indicating acceptable health risks. Collectively, our innovation on cumulative risk assessment of TCM and TCM decoction provides a novel strategy with the main purpose of improving population health.